Missing/wrong data?
Log in to edit
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial
scientific article published on May 7, 2012
Author/s
author: Kathrin Jansen, Leszek Szenborn, Jacek Wysocki, Helen Marshall, Maria Garces-Sanchez, Federico Martinón-Torres
Work details
Publication date
May 7, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.